Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 9Stomach Neoplasms 2Sarcoma 2Prostatic Neoplasms 2Ovarian Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Uterine Cervical Neoplasms 1Resectable MMR-deficient Solid Tumors 1Rectal Neoplasms 1Pancreatic Neoplasms 1Oropharyngeal Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Microsatellite Stable Rectal Carcinoma 1Melanoma 1Hemangiosarcoma 1Gliosarcoma 1Glioma 1Glioblastoma 1Fibrolamellar hepatocellular carcinoma 1Esophageal Neoplasms 1Endometrial Neoplasms 1Diffuse Intrinsic Pontine Glioma 1Diabetes Mellitus, Insulin-Dependent, 12 1Colonic Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Hepatocellular 1Adenocarcinoma Of Esophagus 1

Interventions

tremelimumab 2pembrolizumab 2Nivolumab 2Carboplatin 2poly ICLC 1osimertinib 1lenvatinib 1durvalumab 1cemiplimab 1balstilimab 1Vascular Endothelial Growth Factor A 1Peptides 1Pemetrexed 1Paclitaxel 1Ipilimumab 1Docetaxel 1Blood Specimen Collection 1Antibodies, Bispecific 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Diabetes Mellitus, Insulin-Dependent, 12 × balstilimab × 90 days × Clear all
NCT05571293 2026-05-22

NEST-1

Weill Medical College of Cornell University

Phase 2 Active not recruiting
26 enrolled 15 charts
Gastrointestinal

Diabetes Mellitus, Insulin-Dependent, 12, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡